Unknown

Dataset Information

0

Protection against SHIV-KB9 infection by combining rDNA and rFPV vaccines based on HIV multiepitope and p24 protein in Chinese rhesus macaques.


ABSTRACT: Developing an effective vaccine against HIV infection remains an urgent goal. We used a DNA prime/fowlpox virus boost regimen to immunize Chinese rhesus macaques. The animals were challenged intramuscularly with pathogenic molecularly cloned SHIV-KB9. Immunogenicity and protective efficacy of vaccines were investigated by measuring IFN-? levels, monitoring HIV-specific binding antibodies, examining viral load, and analyzing CD4/CD8 ratio. Results show that, upon challenge, the vaccine group can induce a strong immune response in the body, represented by increased expression of IFN-?, slow and steady elevated antibody production, reduced peak value of acute viral load, and increase in the average CD4/CD8 ratio. The current research suggests that rapid reaction speed, appropriate response strength, and long-lasting immune response time may be key protection factors for AIDS vaccine. The present study contributes significantly to AIDS vaccine and preclinical research.

SUBMITTER: Li C 

PROVIDER: S-EPMC3299295 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Protection against SHIV-KB9 infection by combining rDNA and rFPV vaccines based on HIV multiepitope and p24 protein in Chinese rhesus macaques.

Li Chang C   Shen Zhenwei Z   Li Xiao X   Bai Jieying J   Zeng Lin L   Tian Mingyao M   Song Ying Jin YJ   Ye Ming M   Du Shouwen S   Ren Dayong D   Liu Cunxia C   Zhu Na N   Sun Dandan D   Li Yi Y   Jin Ningyi N  

Clinical & developmental immunology 20120226


Developing an effective vaccine against HIV infection remains an urgent goal. We used a DNA prime/fowlpox virus boost regimen to immunize Chinese rhesus macaques. The animals were challenged intramuscularly with pathogenic molecularly cloned SHIV-KB9. Immunogenicity and protective efficacy of vaccines were investigated by measuring IFN-γ levels, monitoring HIV-specific binding antibodies, examining viral load, and analyzing CD4/CD8 ratio. Results show that, upon challenge, the vaccine group can  ...[more]

Similar Datasets

| S-EPMC8144500 | biostudies-literature
| S-EPMC4016570 | biostudies-literature
| S-EPMC1570341 | biostudies-literature
| S-EPMC10117998 | biostudies-literature
| S-EPMC6533011 | biostudies-literature
| S-EPMC5978417 | biostudies-literature
| S-EPMC3126489 | biostudies-literature
| S-EPMC6042791 | biostudies-literature
| S-EPMC2141831 | biostudies-literature
| S-EPMC3229503 | biostudies-literature